Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Novartis
Federal Trade Commission
Fuji
Healthtrust
Merck
Dow
US Department of Justice
Julphar
QuintilesIMS

Generated: January 17, 2018

DrugPatentWatch Database Preview

Chlorprothixene - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for chlorprothixene and what is the scope of chlorprothixene freedom to operate?

Chlorprothixene
is the generic ingredient in one branded drug marketed by Roche and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

Summary for chlorprothixene
Medical Subject Heading (MeSH) Categories for chlorprothixene

US Patents and Regulatory Information for chlorprothixene

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche TARACTAN chlorprothixene CONCENTRATE;ORAL 016149-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche TARACTAN chlorprothixene TABLET;ORAL 012486-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche TARACTAN chlorprothixene INJECTABLE;INJECTION 012487-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche TARACTAN chlorprothixene TABLET;ORAL 012486-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche TARACTAN chlorprothixene TABLET;ORAL 012486-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche TARACTAN chlorprothixene TABLET;ORAL 012486-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Medtronic
Johnson and Johnson
Novartis
Chubb
Cantor Fitzgerald
Queensland Health
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot